A study on the effectiveness of the new obesity medication tirzepatide found that continued use can lead to significant weight loss and a reduction in diabetes. The medication, taken weekly by injection, has shown promising results over a three-year period, with weight loss stability and improved quality of life reported by patients. The medication is approved for obesity treatment and has been well-tolerated without safety concerns. However, challenges such as low adherence due to costs, shortages, and side effects exist. Patients, healthcare professionals, and researchers advocate for access to effective obesity treatments to prevent complications like diabetes and improve overall health outcomes.
Source link
New weight loss medication shows long-term benefits in preventing diabetes and significant weight loss
